Literature DB >> 20798916

[Guideline intentions of the German Society of Psychiatry, Psychotherapy and Nervous Diseases (DGPPN)].

T Wobrock1, F Schneider, P Falkai.   

Abstract

The practice guidelines of the German Society of Psychiatry, Psychotherapy and Nervous Diseases (DGPPN) include systematically developed and evidence-based treatment recommendations which assist clinicians and patients in making decisions about appropriate treatment for specific conditions. The intentions of practice guidelines are to improve the quality of care and the outcome of mental diseases. This paper describes the methodology behind the development of the guidelines and lists the already existing practice guidelines as well as the guidelines actually being developed. In addition, it is outlined how quality indicators may be derived from guidelines. A major aim of the German Society of Psychiatry, Psychotherapy and Nervous Diseases (DGPPN) is to assure the quality of inpatient and outpatient care of the mentally ill by developing evidence-based consensus guidelines.

Entities:  

Mesh:

Year:  2010        PMID: 20798916     DOI: 10.1007/s00115-010-3082-9

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  4 in total

1.  Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data.

Authors:  Alan D Lopez; Colin D Mathers; Majid Ezzati; Dean T Jamison; Christopher J L Murray
Journal:  Lancet       Date:  2006-05-27       Impact factor: 79.321

2.  [Guidelines based on decision support software. Quality management in neurological outpatient schizophrenia treatment].

Authors:  B Janssen; R Menke; F Pourhassan; D Gessner-Ozokyay; R Peters; W Gaebel
Journal:  Nervenarzt       Date:  2006-05       Impact factor: 1.214

3.  Improving quality of care for depression: the German Action Programme for the implementation of evidence-based guidelines.

Authors:  Martin Härter; Isaac Bermejo; Günter Ollenschläger; Frank Schneider; Wolfgang Gaebel; Ulrich Hegerl; Wilhelm Niebling; Mathias Berger
Journal:  Int J Qual Health Care       Date:  2005-10-31       Impact factor: 2.038

4.  [Guideline conformity and outcome of inpatient treatment for schizophrenia. A clinical comparison].

Authors:  B Janssen; S Weinmann; M Berger; M Härter; T Held; M Leipert; H J Luderer; M Schwarz; T Steinert; W Gaebel
Journal:  Nervenarzt       Date:  2005-03       Impact factor: 1.214

  4 in total
  6 in total

1.  [A new evidence and consensus-based German guidelines for diagnosis and treatment of bipolar disorders].

Authors:  M Bauer
Journal:  Nervenarzt       Date:  2012-05       Impact factor: 1.214

Review 2.  [Treatment pathways in the care of patients with schizophrenia and depression].

Authors:  H J Salize; E Voß; A Werner; P Falkai; I Hauth
Journal:  Nervenarzt       Date:  2015-11       Impact factor: 1.214

3.  [Treatment of Alzheimer's disease according to the S3 guidelines on dementia. Choline esterase inhibitors for all and for ever?].

Authors:  Thomas Lempert; Tom Bschor
Journal:  Nervenarzt       Date:  2011-01       Impact factor: 1.214

4.  [Responsible dealing with sexuality. Recommendations in a clinical institution].

Authors:  R Steinberg; C Rittner; S Dormann; D Spengler-Katerndahl
Journal:  Nervenarzt       Date:  2012-03       Impact factor: 1.214

Review 5.  [National and international schizophrenia guidelines. Update 2013 regarding recommendations about antipsychotic pharmacotherapy].

Authors:  A Hasan; T Wobrock; W Gaebel; B Janssen; J Zielasek; P Falkai
Journal:  Nervenarzt       Date:  2013-11       Impact factor: 1.214

6.  The effects of a clinical care pathway for schizophrenia: a before and after study in 114 patients.

Authors:  Bruno Steinacher; Lieselotte Mausolff; Burkhard Gusy
Journal:  Dtsch Arztebl Int       Date:  2012-11-16       Impact factor: 5.594

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.